Products
Deucravacitinib
Use and description |
| Deucravacitinib (BMS-986165) is the first and only novel, oral, selective tyrosine kinase 2 (TYK2) inhibitor in clinical studies across multiple immune-mediated diseases. Deucravacitinib’s selectivity is driven by a unique mechanism of action that is distinct from other kinase inhibitors. |
Physical Characters and Index |
English name: BMS-986165 CAS number: 1609392-27-9 Molecular formula: C20H22N8O3 Molecular weight: 422.45 |
